Upcoming conferences

 

Trans-Hit Bio to attend The Global Biobank Week
Stockholm, Sweden, September 13-15, 2017

 

 

Come see us at Global Precision Medicine & Biomarkers leaders summit, Booth 1
Munich, Germany, September 21-22, 2017

 

Trans-Hit to attend the 2nd Annual Biomarkers & Precision Medicine USA Congress
San Diego, USA, 9-11 October

Come see us at the Molecular Med Tri-con, Booth 612
San Francisco - USA, February 11-16, 2018

Come see us at the 13th Annual Biomarkers Congress Booth 31
Manchester, UK, 15-16 February 2018

 

PAST CONFERENCES

Come see us at The Next Generation DX Summit, Booth 405
Washington, DC, August 15-18, 2017

Trans-Hit Bio will host a presentation at the Precision Lung Cancer Summit
Boston, July 25-26, 2017

 

Trans-Hit to attend the ASCO General Meeting
Chicago, IL, June 2-6, 2017

1) The importance of Reciprocal Transparency between Biobank and End Users of Samples
2) Tomorrow's need for Biospecimen in Pharma Research

 

 

 

Trans-Hit Bio attended: Global Precision Medicine Summit
Berlin, Germany, March 2-3, 2017

Trans-Hit Bio presented:
'How to expedite access to large biospecimen collections needed to validate liquid biopsy based assays' at The Molecular Medicine Tri Conference

San-Francisco, February 19-24, 2017. (Booth 605-607)

 

Trans-Hit Bio attended: 12th Annual Biomarkers Congress

Manchester, UK, February 21-22, 2017

Trans-Hit Bio Attended The ISBER 2016 Regional Meeting

Bethesda, MD, USA, November 7-8, 2016

Trans-Hit Attended The Europe Biobank Week
Vienna, Austria, September 13-16, 2016

Trans-Hit Attended The Next Generation DX Summit, Booth TT10

Washington, DC, USA, Augsut 23-26, 2016

Trans-Hit Hosted Two Presentations at The Biorepositories & Management Conference
Boston, MA, USA, September 5-7, 2016

Round table discussion:
Traceability of Biospecimen (patient - biobank - end-user): A need for Academic Biobank and Industry

Presentation:
Main impediments to increasing collaborations between Industry and Academic Biobank: some solutions